Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Get Real-Time News and Alerts for Your Portfolio Leqembi is indicated for Alzheimer’s disease in patients with Mild Cognitive ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...

Eisai and Biogen are one step away from deploying a more convenient version of their jointly developed Alzheimer’s treatment ...

The study suggests that mild cognitive impairment is linked to blood vessel dysfunction in the brain’s temporal lobes. The ...

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...

The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions.

Sleep has been shown to have a long list of physical and mental health benefits, and now a new study suggests it could also ...

which could serve as a valuable risk factor for dementia. By being able to measure brain age with EEG, we are potentially paving the way for a proactive and scalable approach to early screening and ...

Looking at Firefly’s year-to-date (YTD) performance, the company has shown an incredible gain of +38.49%. In comparison, the broader market, as represented by the S&P 500, is down -1.61% YTD. This ...